Archive for the ‘Government Behaving Badly’ Category

Important Meeting In Tennessee!

a

Educated and informed people have an opportunity to make an impact on the life expectancies of opioid addicts in Eastern Tennessee!

The Tennessee Health Services and Development Agency is holding a fact-finding public hearing, regarding the certificate of need application for a methadone treatment facility, proposed to be located in Johnson City, Tennessee.

This meeting will be held on May 28th, 5pm, in the Jones Meeting Center, Johnson City Public Library, on 100 West Millard Street in Johnson City, Tennessee.

There’s a desperate need for medication-assisted treatment of opioid addiction in that part of Tennessee. Opioid addicts can get treatment in office-based Suboxone practices now, but as discussed in previous entries on this blog, this can be an expensive treatment. Many addicts don’t have insurance to pay for this treatment, which is then out of financial reach. For other addicts, buprenorphine, being a partial opioid, isn’t strong enough. Methadone can work beautifully for patients who don’t do well on buprenorphine (known to most as Suboxone or Subutex). However, there are no methadone treatment programs in Eastern Tennessee, so a clinic in that area is desperately needed. The nearest in-state clinic is in Knoxville.

People who know methadone works and saves lives need to go to this meeting to be heard. I suspect there will be people there who know next to nothing about methadone who are nonetheless opposed to a clinic. We’ve all met them: people adamantly opposed to methadone even though their brains are uncomplicated with any actual knowledge of methadone. And there will the NIMBYs, the not-in-my-backyard people.

Citizens who know there are scientific studies showing that methadone is an evidence-based treatment shown to save lives need to go and be heard. Tell other people at the meeting about the forty years’ of studies consistently showing that methadone maintenance reduces overdose death rates, improves overall physical and mental health, increases rates of employment, reduces the risk of suicide, dramatically reduces criminal activities of opioid addicts (by a whopping 91%), and reduces the rates of new cases of HIV.

It’s hard to imagine the certificate of need could be denied, but remember attempts to locate a methadone treatment center in Eastern Tennessee have tried – and failed – ten times before. Let’s hope science and reason can win over ignorance and prejudice.

If, like me, you can’t make the meeting, please send a letter to:

Tennessee Health Services and Development Agency
Melanie M. Hill, Executive Director
Frost Building, 3rd floor
161 Rosa Parks Boulevard
Nashville, TN 37243

Update on the State of Denial: Is the Tide Finally Turning?

Word -HELP with syringe on white pills.

After my last post, I heard from Steve Kester, the co-owner and manager of the company seeking to open an opioid treatment program in Johnson City, Tennessee. He’s had great news: the certificate of need was approved. In addition, he was invited to write a Sunday editorial in the Johnson City Press, correcting mistaken information and explaining more about how an opioid treatment program works.

It’s a great article, and you can read it here: http://www.johnsoncitypress.com/Opinion/article.php?id=105510#axzz2PxuPsb4q

Granted, it’s still posted in the paper as an opinion piece, though every bit of data he describes is science, proven in multiple studies. That’s much more than an opinion. But still, it’s progress for the paper to print this side of the treatment issue.

In the article, Mr. Kester makes several points that should clear misunderstandings people have about methadone clinics. He describes how methadone is not the same thing as methamphetamine, even though both words begin with M-E-T-H. It is still surprising how many people don’t know the difference. He also talks about how an opioid treatment program is not a pill mill but exactly the opposite of a pill mill. He outlines the benefits to the community when opioid addiction is treated. Instead of 80% of opioid addicts committing crimes to support their addiction, 80% of addicts enrolled in medication-assisted treatments are employed and are productive members of society. He reminds us that many Iraq/Afghanistan war vets are among the addicts seeking treatment for their pain pill addiction. Also, he agrees that opioid treatment programs should not be located in residential areas, and his program will not be located in a residential area.

Towards the end of the article, Mr. Kester reminds readers that denying access to care for people who are sick with addiction is illegal, a violation of federal law, since addiction is covered under the Americans with Disabilities Act of 1973.

He was polite in his article, but I would add that if Johnson City throws up unreasonable roadblocks, it’s likely the town will be sued in federal court. If so, they are sure to lose, given recent cases setting precedent. Awards have been in the high six-figures, so citizens of Johnson City and their local government representatives should think hard about whether it’s worth it break the law to prevent addicts from getting evidence-based treatments.

There’s a mischievous part of me that hopes a town in Tennessee – again, for the eleventh time – breaks the law and denies treatment by blocking the opening of an opioid treatment center. It would amuse me greatly to see town officials get the pants sued off of them. But that’s not in the best interests of people suffering from addiction. Hopefully this opioid treatment program can be opened forthwith.

Just another reminder to write to this address to support opioid addiction treatment with medication-assisted therapies:
Health services and Development Agency
The Frost Bldg 3rd Floor
161 Rosa Parks Blvd
Nashville, TN 37243

The State of Denial (Tennessee) gets Another Chance

aaaprejudice and ignorance

If you read my blog, you know Tennessee is a frequent target of my ire. I’ve been aghast and distressed at Tennessee’s refusal to allow an opioid treatment program to open in the Eastern part of that state. Hopefully, that’s about to change.

Now a new opioid treatment program has applied for a certificate of need with Tennessee’s Department of Mental Health and Substance Abuse Services, asking for permission to locate a methadone clinic in Eastern Tennessee. Sources say this is the eleventh attempt to locate an opioid treatment program that prescribes methadone in that part of Tennessee. In 2002, approval was given but then withdrawn due to a technicality.

Even if the certificate of need is approved, this company faces stiff opposition from the modern-day equivalent of villagers with pitchforks, demanding that no treatment center be located near them. This is the ugly face of modern day NIMBYism, and it violates the American with Disabilities Act, a topic of a past blog. (See November 14, 2012) It’s illegal, and past federal court rulings have sent a clear message to towns that violated the ADA in this way, with high six-figure fines.

I’m surprised anyone wants to put a new clinic in Tennessee, given its recently passed anti-evidence-based regulations on methadone clinics, but I’m pleased. Eastern Tennessee probably has more untreated opioids addicts per acre than anywhere else in the nation. Tennessee has the 13th highest opioid overdose deaths per capita, compared to all other states, and is ranked number two in the kilogram of opioids prescribed per capita. [1]

Yet it has only a small number of opioid treatment programs. The nearest methadone clinic to Eastern Tennessee is located in Knoxville, and in bordering states. These states treat the opioid addicts Tennessee is neglecting. The certificate of need submitted by the petitioning opioid treatment program says that around one thousand opioid addicts are now traveling one or two hundred miles round trip each day for treatment. You know there are thousands more getting no treatment at all.

The state will make a decision about the certificate of need request this summer. Of course, any educated interpretation of data would conclude that the certificate of need should be approved forthwith. As I said, you can’t throw a rock in Eastern Tennessee without hitting an opioid addict. But so many people don’t know anything about the benefits of methadone.

Lack of knowledge about methadone does not prevent people in positions of authority from taking a strong stance against it. For example, this is a quote in the Johnson City Press from Roger Nave, committee chairman of the public safety committee of the county where Johnson City is located: “We have top-class medical facilities in this area to deal with any problem that our citizens have. The addicts do need help and support, but methadone is not the answer to their problems.”

Does Mr. Nave actually know any facts about methadone?? Does Mr. Nave know that the treatment of opioid addiction with methadone is one of the most strongly evidence-based medical treatments in all of medicine? Does he know that we have over forty years’ of studies that show the treatment of opioid addiction with methadone reduces overdose death rates and suicide rates? Does he know it improves employment rates and dramatically reduces crime rates? Does he know addicts treated with methadone have better physical and mental health? Does he know that for each dollar spent on methadone treatment, taxpayers save four dollars, mostly in reduced incarceration costs? Does he know that methadone treatment of opioid addiction significantly reduces the incidence of HIV in intravenous opioid addicts? [2,3,4]

Eastern Tennessee now has Suboxone providers, and these doctors have likely saved hundreds of lives. Buprenorphine is a great medication, and I prefer prescribing it rather than methadone because of its better safety record. It works on the same principle as methadone: both are long-acting opioids that can be dosed once daily to keep opioid addicts from having withdrawal or craving, thus freeing them to focus on changing their lives.

But buprenorphine is not strong enough for all opioid addicts. It doesn’t work for all opioid addicts. In fact, no treatment works for all opioid addicts, even medication-assisted treatment with buprenorphine and methadone. Some are too sick for these medications, and some aren’t sick enough.

Suboxone programs are too expensive for many addicts. Yesterday I called three programs in Tennessee to get an idea of their prices. A month’s worth of treatment is around $400, including doctors’ visits, group and individual counseling, and drug tests. The medication is not included in this cost, and can cost an additional $240 to $900 per month, depending on the dose of medication. Opioid addicts without health insurance can’t afford that kind of treatment. Methadone programs usually cost $9-$11 per day, and addicts can pay as they go.

At least one big Suboxone program in Johnson City doesn’t do maintenance treatment, but only a few months of detox, despite more studies showing greater benefit with longer treatment. Some addicts are forced to come off Suboxone before they are ready, a recipe for relapse.

Suboxone is a valuable option for opioid addicts, but let’s make all forms of evidence-based treatment available for opioid addicts. Why not let addiction specialist doctors decide which treatment is appropriate, rather than government officials without any medical training?

With so many untreated opioid addicts in Eastern Tennessee, all forms of evidence-based treatments need to be available. At present, health officials in Tennessee push patients into medication –free treatments. These can work, if patients are given long enough treatment and if they can afford it. In my experience, inpatient programs in Eastern Tennessee seem to keep patients for two or three weeks, instead of two or three months. This is understandable, since Medicaid isn’t known for generous reimbursement, and private insurance rarely pays for longer treatments. Patients with no insurance at all are often asked to bring money up front to pay for treatment. Asking an addict to bring a few thousand dollars with them to start inpatient treatment doesn’t work, for obvious reasons. Even treated patients are sent back home to the same living situation, and relapse quickly. Using inpatient detox alone for five to seven days has always given relapse rates of 92%, with most relapsing within the first week.

Tennessee state officials have a chance to save lives, if only they can put aside their personal biases and look at the science supporting medication-assisted treatments. It’s the right thing to do. It’s a bargain, too. Patients are mostly self-pay, so it doesn’t cost taxpayers anything. Even from a purely economic view, methadone treatment would save taxpayers money.

If you support medical treatment of opioid addiction with evidence-based therapies, please write to the state and let them know. If you are an addict who has been helped by methadone, send a letter to the below address. If you are a family member who has seen the benefits of methadone treatment in your loved one, tell the people in government. This is the time to act. Don’t let this opportunity to slip by. Send your letter to:

Tennessee Health Services and Development Agency
Melanie M. Hill, Executive Director
Frost Building, 3rd Floor
161 Rosa L. Parks Boulevard
Nashville, TN 37243

1.http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6043a4.htm?s_cid=mm6043a4_w
2.http://international.drugabuse.gov/sites/default/files/pdf/methadoneresearchwebguide.pdf
3.California Department of Drug and Alcohol Programs, 2004, California drug and alcohol treatment assessment (CALDATA) California Department of Alcohol and Drug Programs. California Drug and Alcohol Treatment Assessment (CALDATA), 1991-1993 [Computer File]. ICPSR02295-v2. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2008-10-07. doi:10.3886/ICPSR02295
4.http://www.asam.org/docs/publicy-policy-statements/1methadone-rev-10-061.pdf?sfvrsn=0#search=”methadone

Medical Care in Opioid Treatment Programs: Red Tape

aaared

At recent meetings of OTP medical directors in my state, we’ve had renewed discussions about how to provide primary care and psychiatric care to program patients.

Opioid treatment centers that are able to offer a wider array of services than just dosing with methadone show better patient retention in treatment and better patient outcomes. This means that the more services that are added, like psychiatric care, primary medical care, help with employment, and family counseling services, patients in those programs have better outcomes than patients in programs that offer only medication and individual counseling. This shouldn’t be a surprise; it makes sense to me. (1)

The problem is, of course, these extra services cost more to the treatment program. If you want to offer psychiatric services, a psychiatrist must be hired, usually on a contract basis, to be available during dosing hours. If the program’s medical director is a psychiatrist, that doctor has to be paid for the extra time it takes to provide the extra care. More commonly, patients are referred to other places for low-cost psychiatric help.

It’s the same with medical care. In order to offer any level of primary care, you have to hire a doctor, unless patients are asked to pay extra for this. Most patients can barely afford basic treatment, so extra expenses can’t be obtained.

At both of the programs where I work, I used to offer some level of primary and psychiatric care. I used to try to treat uncomplicated mental illness like depression and anxiety disorders, and non-chronic, low-intensity primary care illnesses. Of course I referred patients who needed ongoing medical or psychiatric care, but was able to provide them some level of care until they got an appointment, or were able to afford an appointment. I already knew their history of addiction and didn’t prescribe anything that would interact with methadone or buprenorphine, of course. It didn’t cost the patient anything to see me for these extra services, so it saved patients money. I saw six or seven such patients each time I worked at the clinic, and they didn’t necessarily need any appointment. It seems like a good thing all around.

But then came time for us to have our first CARF survey in one program.

Treatment centers want to be certified by the Commission of the Accreditation of Rehabilitation Facilities (CARF). CARF personnel are invited to facilities for a voluntary inspection. These OTPs hope to be given a sort of seal of approval by this agency. The CARF agency inspects mental health, substance abuse treatment, and physical rehabilitation facilities, as well as youth and family service facilities. Accreditation is important because it demonstrates the facility is providing good care.

Our CARF survey went fair in most regards. We got a one-year accreditation, and the CARF surveyors had good things to say about our clinic regarding our dedication to our mission to help our patients. They said great things about the staff enthusiasm and outlook. But they did not like how I was providing primary physical and mental healthcare. The CARF people supported the idea of providing primary care to patients, but they had many recommendations about how to do it. They wanted implementation of a few policies and procedures. This is what they recommended, verbatim:

F.2.a.(1) through F.2.b.(16)
It is recommended that ongoing documented training and education on medications be provided to the person served, family members, individuals identified by the person served, the team, and service providers. This ongoing training should include how the medication works; risks associated with each medicine; the intended benefits as related to the behavior or symptom targeted by the medication; side effects, contraindications, and potential implications between medications and diet/exercise; risks associated with pregnancy; the importance of taking medications as prescribed, including, when applicable, the identification of potential obstacles to adherence; the need for laboratory monitoring; the rationale for each medication; early signs of relapse related to medication efficacy; signs of nonadherence to medication prescriptions, including alcohol, tobacco, caffeine, illicit drugs, and alternative medications; instructions on self-administration, when applicable; wellness management and recovery planning; and the availability of financial supports and resources to assist the persons served with handling the cost associated with medications.

F.a.(1) through F.4.c.(3)
It is recommended that, when medications are prescribed for or provided to a person served (including those self-administered medications), an up-to-date individual record of all medications, including nonprescription and non-psychoactive medications, include the name of the medication; the dosage; the frequency; instructions for use, including the method/route of administration; and the prescribing professional. The program should provide ready access to the telephone number of a poison control center to the program personnel and the person served. Written procedures that address how the medication will be integrated into the overall plan of the person served should be available. There should be a process for identifying, responding to, documenting, and reporting medication reactions and actions to be followed in case of emergencies related to the use of medication.

F.5.a.through F.5.n.
It is recommended that, as the organization prescribes medications, it implement written procedures that include compliance with all applicable local, state or provincial and federal laws and regulations pertaining to medications and controlled substances, including on-site pharmacy services and dispensing. Written procedures should include the active involvement of the persons served, when able, or their parents or guardians, when appropriate, in making decisions related to the use of medications; the availability of a physician, pharmacist, or qualified professional licensed to prescribe for consultation 24 hours a day, 7 days a week; documentation and reporting of observed and/or reported medication reactions and medication errors; and a review of past medication use, including effectiveness, side effects, and allergies or adverse reactions. Written procedures should include the identification of alcohol, tobacco, and other drug use; use of over-the-counter medications; use of medications by women of childbearing age; use of medications during pregnancy; special dietary needs and restrictions associated with medication use; necessary laboratory studies, tests, or other procedures, when applicable; documented assessment of abnormal involuntary movements at the initiation of treatment and every six months thereafter for persons served receiving typical antipsychotic medications; when possible, coordination with the physician(s) providing primary care needs; and review of medication use activities, including medication errors and drug reactions, as part of the quality monitoring and improvement system.

F.6.a. through F.6.f.
If the organization provides prescribing of medications, it is recommended that it implement written procedures that include screening for common medical co-morbidities using evidence- or consensus-based protocols; evaluation of co-existing medical conditions for potential medications impact; identifying potential drug interactions, including the use of over the counter or homeopathic supplements; documentation or confirmation of informed consent for each medication prescribed, when possible; continuing a prescribed medication if a generic medication is not available; and continuity of medication use, when identified as a need in a transition plan for a person served.

F.7.a.through F.7.b.(2)
It is recommended that, as an organization that provides prescribing of medications, it demonstrate, to the extent possible, the use of treatment guidelines and protocols to promote state-of-the-art prescribing and ensure the safety of the person served. It is also recommended that a program of medication utilization evaluation include measures of effectiveness and satisfaction of the person served.

F.8.a. through F.8.e.(2)
As an organization that provides prescribing of medications, a documented peer review should be conducted at least annually on a representative sample of records of persons for whom prescriptions were provided in order to assess the appropriateness of each medication as determined by the needs and preferences of each person served and the efficacy of the medication. It should be used to determine if the presence of side effects, unusual effects, and contraindications were identified and addressed and if necessary tests were conducted and used to identify the use of multiple simultaneous medications and medication interactions.

F.9.a. through F.9.c.
It is recommended that information collected from the peer review process be reported to applicable staff, used to improve the quality of the services provided, and incorporated into the organization’s performance improvement system.

Huh?
I was overwhelmed. I’m a relatively intelligent person, but I’m still fuzzy on exactly what they mean. Here are some of my concerns:
-I already record a full history and physical on each patient, and have a record of all medications each patient takes. But apparently the way I’m doing this isn’t adequate, and I’m left to wonder what the specifics of their recommendations would look like.
-Get a signed informed consent in order for me to write a prescription? This is not generally done in primary care. Maybe if I were administering chemotherapy…but I was prescribing things like penicillin for an infected tooth. I’m not sure what the justification for this is in a methadone clinic population.
-Apparently I need to give each patient a written summary of all side effects of a prescribed medication. I don’t do this in primary care, because the pharmacy does all of that. Each time a prescription is filled, they give a long sheet of possible side effects. What’s the rationale for redundancy?

When faced with the task of complying with all of these recommendations, the owners of this clinic said forget it. They told me to prescribe only the methadone and buprenorphine, and when I saw other medical problems, provide a referral to doctors in the community. That way, the opioid treatment center won’t be penalized by CARF for not implementing…well, the byzantine recommendations above. I still don’t know exactly what CARF meant. Maybe I should say I don’t know what their recommendations would look like in real life.

Not providing any primary care took pressure off of me, but our patients were left with less medical care than they already have, which is little. It’s really hard to “coordinate care” for patients who have no insurance and no money. Yes, I know there are free clinics available in many areas, but they only provide a limited amount of care and follow-up. And specialty care is unattainable.

At our next CARF survey a year later, our program got good marks from CARF, and a three-year accreditation, instead of only one year. Without requirements around primary care to meet, it was simple.

CARF does a needed service, but in many matters I think it’s important to pull back to see the whole picture. Plus, drop the jargon and use words that make sense, please. It’s similar to the paperwork requirements for Medicaid – most of this paperwork is probably needed in some form or fashion, but I’ve seen the repetition. Leave counselors time to counsel.

Regulations are important. But don’t make the regulations so obscure and onerous that most clinics stop providing any extra care because of the difficulty meeting these requirements.

I’d love to see my state’s methadone authority work with the CARF organization. Maybe together they could issue new guidelines for primary care in opioid treatment programs that make sense. Then programs may be more likely to offer extra services.

(1) McLellan AT, Arndt IO, Metzger DS, Woody GE, O’Brien CP. The effects of psychosocial services in substance abuse treatment. JAMA 1993;269(15):1953-59

FDA Favors More Restrictions on Hydrocodone

aaaaovermed

Last week, a panel of experts at the Food and Drug Administration voted in favor of new regulations on prescription pain pills containing hydrocodone. Hydrocodone is the active ingredient in name brand opioid pain relievers like Vicodin and Lortab, which contain mixtures of hydrocodone and acetaminophen. These preparations of hydrocodone are presently Schedule III controlled substances.

Any potentially addicting drug is given a Schedule designation from I through V. Schedule I reserved for drugs with little medical use and very high abuse potential, Schedule II for medications with medical uses but high addicting potential, and so on, down to level V, reserved for medications with slight risk for addiction but with medical uses.

At present, regulations for Schedule II medications like Opana and methadone are more stringent than for Schedule III medications like Vicodin and Lortab. Schedule III medications can be written with refills if the physician decides this is necessary and prudent. Schedule III medications can be called in by telephone, while Schedule II can’t be called in by a physician or anyone else, and even the written prescriptions can’t be refilled. A new prescription must be written by the doctor if a Schedule II pain medication is to be continued.

The New York Times article didn’t explain whether the FDA aims to recommend a change in the schedule designation of hydrocodone, or if new regulations will be put in place in some other way. This matters a great deal, since in some states, only physicians can write for Schedule II medications, and nurse practitioners and physician assistants can’t prescribe them at all.

Any reader of my blog knows I’m in favor of more cautious prescribing of opioids by all providers, because loose prescribing habits are one causative factor in our present epidemic mess of opioid addiction. However, we can over-react to the crisis, to the point of making it unreasonably difficult for patients with acute pain to get reasonable care.

In states where physician extenders like nurse practitioners and physician assistants aren’t allowed to prescribe Schedule II medications, the outcome could be dire. Some communities rely on these providers because there are few physicians in the area. This new decision could make it very difficult to get appropriate pain medication for even short-term use in rural areas with few physicians.

There are dozens of medical situations when it’s handy to be able to call in a refill of hydrocodone when pain extends longer than expected. If refills can’t be called in, doctors and dentists may actually decide to prescribe more pills at a time, knowing they won’t have the luxury of calling in a few more pills.

The New York Times article mentioned nursing home patients as one group who could be adversely affected by the new recommended changes. Many are frail, and unable to travel back and forth to a doctor’s office to get a new prescription each time one is needed for a chronic pain condition. In some areas, doctors come to see the patients at the nursing home facility, though not in all facilities. Home-bound patients with chronic pain would be required to travel to doctors’ offices.

Hydrocodone is the number-one prescribed opioid in our country, and certainly many pain pill addicts have used it illicitly. But by the time addicts come to me for treatment, it’s rare for hydrocodone to be only opioid being abused. Most of the addicts I admit to treatment say they may have started with hydrocodone, but switched to more powerful opioids at some point in their addiction. Perhaps hydrocodone is more of a “gateway” opioid for these addicts.

Restricting access to hydrocodone will likely reduce addiction, because studies do show that decreased access to drugs (including alcohol) decreases the number of people who become addicted. But let’s not overlook the hardships over-regulation may cause to patients with acute pain.

It will be interesting to see what happens if/when these new recommendations take effect.

Kafkaesque

Quackery

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Once again, Tennessee’s Department of Mental Health and Substance Abuse Services has managed to bitch slap science in the face.

Yesterday I asked a knowledgeable friend what he knew about Tennessee’s final version of the Opioid Treatment Program regulations, and he sent me a file containing the final revisions. The document also records commentary and objections of various stakeholders (trendy term for, “the people who are really affected”). I read this material late last night, and went to bed feeling depressed and defeated.

This morning, I reflected on the progress of science. Particularly in the field of medicine, we’ve made great strides, largely after the advent of the scientific method of clinical trials. Before we knew how to test different treatment methods in clinical trials, medical treatment of illness in the U.S. depended on the individual doctor’s anecdotal experiences with patients, and traditional healing methods. When asked why they used leeches and bloodletting, the doctor would say “Because that’s the way we’ve always done it.” Doctors did the best they could with limited scientific data.

In the early part of the twentieth century, European scientists and research doctors began using scientific methods to determine which treatments really worked. These methods included the use of randomized trials comparing one treatment to another, and the use of statistics to analyze results. As a result, medical knowledge and practice advanced rapidly in Europe, and the U.S. medical establishment lagged far behind. U.S. medical schools and the doctors they produced began to have terrible reputations worldwide.

Appalled at the poor quality of care provided by many practicing physicians in the U.S., the Carnegie Foundation asked a group of scientists to investigate what should be recommended to bring the U.S. up to date with the rest of the world. The result of this mission was contained in the “Flexner Report,” written by Dr. Abraham Flexner.

The Flexner report was a great document. It outlined in great detail the failings of U.S. medical schools and medical establishment. At that time, 1910, many schools were for-profit affairs owned by a few physicians more interested in collecting tuition than teaching accurate material. Much of what young doctors were taught was outdated and inaccurate. The Flexner Report stated what doctors at the few good medical schools already knew: many poorly trained doctors throughout the U.S. offered so-called cures with little or no evidence to support their treatments. Citizens were not getting scientifically-based treatments then available in other parts of the world.

As a result of this report, many deficient medical education programs were shut down. Flexner recommended that only medical schools whose teachings adhered to the accepted scientific method should be allowed to remain open. Because of the Flexner report and the actions taken based on its findings, scientific method eliminated the quackery that was popular in the U.S. in the early 1900’s. The United States followed the recommendations of the Flexner Report, and now U. S. medical care and research meets or exceeds standards in other countries.

But in Tennessee, the leeches are back.

From four decades worth of research into the treatment of opioid addiction with methadone, we know what works and what doesn’t work. We have a coherent, evidence-based body of knowledge surrounding best practices for the treatment of opioid addiction with methadone. Numerous agencies have produced documents containing evidence supporting the use of methadone maintenance in the treatment for opioid addiction: National Institutes of Health, Center for Disease Control and Prevention, Institute of Medicine, National Institute of Drug Abuse, Center for Substance Abuse Treatment, and Substance Abuse and Mental Health Services Agency.

Great summaries of this data are easily available in several places: NIDA’s wonderful website at http://international.drugabuse.gov has all the answers to most questions, and references (studies done with scientific method) to support the data. SAMHSA published – for free to anyone who wishes a copy – the Treatment Improvement Protocol 43, often called “TIP 43” for short. To point out the obvious, treatment of a medical illness shouldn’t be decided by how one “feels.” about the treatment. It should – of course – be based on the best science. In response to many of the odd regulations proposed by Tennessee’s Department of Mental Health, many respectable organizations weighed in with their concerns. Usually, they cited data to back up what they claimed was the current, state-of-the-art practices for methadone maintenance treatment of opioid addiction. Groups included not only the present treatment programs currently operating in Tennessee, but also the American Association for the Treatment of Opioid Dependence (AATOD), the National Alliance for Medication-Assisted Recovery (NAMA),

To be fair, the state did acknowledge and change some of their rules on minor things. But when confronted with data that proves their regulations are not best practice, the Tennessee Department of Mental Health basically said, “We disagree.” In other words, “We don’t need no stinkin’ science to tell us how to do things! We know what’s best!”

I can’t stand to go into detail about all the ways in which Tennessee goes back into the dark ages, but here are a few of the most imprudent regulations:

  • Before being allowed into methadone treatment, a new patient must have two years of physical dependence, unless they’ve had a failed abstinence-based treatment attempt and one year of physical opioid dependency.

My beef with this is: we know patients on waiting lists for methadone die at eight times the rate of patients enrolled in methadone treatment. Is Tennessee just hoping addicts will die off ? Also, has Doug Varney (head of the state methadone authority in Tennessee) ever tried getting an opioid addict with no money and no insurance into an abstinence-based Tennessee treatment program lately?

  • The state methadone authority needs to be notified of patients going to doses higher than 100mg
  • No patient can go over 120mg unless first given permission by the state methadoneauthority.

OK, so a non-physician is going to make a medical decision? That sounds like practicing medicine without a license to me…isn’t that a felony? Maybe it’s only a misdemeanor in Tennessee. Seriously, what qualifies a state administrator to make any decisions about the dose of any medication? They have no way to talk to the patient, no way to examine them to get clinical information. Does a pharmacist working as the head of the state’s mental health administration have the experience or knowledge, let alone the authority, to decide the doses appropriate for patients?

Even putting aside the suffering this inane rule will bring to patients, what about the legal implications for the person making these decisions at a state level? What non-doctor would be foolish enough to go on record denying a dose of medication that a doctor thought necessary? It seems like a situation ripe for a lawsuit. Consider the following scenario: patient needs dose increase because she is still having significant withdrawal. Doctor at OTP examines her, makes the clinical decision that she needs a higher dose of methadone. State office worker denies permission for the dose increase. Patient leaves treatment, frustrated that she’s still in opioid withdrawal and can’t become stable. A few weeks later, she dies from a fatal illicit opioid overdose.

Usually I eschew lawyers, since they can complicate a one-car funeral procession, but wouldn’t this be a winnable legal case for the family? But for the interference of the state office worker, the patient may not have dropped out of treatment and died from untreated opioid addiction. And what if the office worker approved the increased dose, and the patient died from a methadone overdose? Is the state, since they approved the increased dose, at risk for any bad outcome that results from the dose increase?

  • With one positive urine drug screen, patients get no take homes for 30 days, and have to do mandatory weekly counseling.

I like the idea of more counseling, but weekly may be difficult for working patients, and we do want them to be able to keep their jobs, right? That is one goal of recovery, right? Besides, removing take homes after only one positive is simply punitive unless there’s imminent danger of overdose.

  • With the fourth consecutive positive urine drug screen within six months, more intense counseling is mandated. Intensive outpatient and residential treatment are listed as options. And if the patient refuses these options, he will be terminated from the opioid treatment program.

I can barely stand to list all the reasons this is a miserable decision. First of all, have you ever tried to get a patient on methadone into a Tennessee Intensive Outpatient Program or residential program? All the ones I’ve dealt with say they must be off methadone before entering, so this is all very Kafkaesque.

In fact, Tennessee’s state methadone authority is Kafkaesque (“Instances in which people are overpowered by bureaucracies, often in a surreal, nightmarish milieu which evokes feelings of senselessness, disorientation, and helplessness.”) [1]

As I said, I’m depressed by the thought of how thoroughly Tennessee’s ignorance has managed – yet again- to bitch slap science in the face.

I think I’ll go back to bad.

  1. Wikipedia, 10/17/2012   http://en.wikipedia.org/wiki/Franz_Kafka

Closing Down a Methadone Clinic

 

I read the front page article in last week’s Alcoholism and Drug Abuse Weekly with mixed emotions. http://www.alcoholismdrugabuseweekly.com/

The state of Minnesota revoked the license of the only methadone treatment program in the city of Duluth and ordered it to shut down. This order was suspended until the outcome of an appeal by the owners on the clinic, Colonial Management Group.

I felt angry and chagrined.  I support methadone treatment programs, both because they conduct one of the most evidence-based treatment interventions in all of medicine, and because that’s the type of setting where I work. I’ve seen the life changing benefits many patients get from methadone treatment. Closing this clinic would deprive opioid addicts of an effective treatment for their addiction in the city of Duluth, and existing patients would be essentially abandoned.

But bad clinics harm the reputations of good clinics. The list of charges against the clinic is appalling, and if true, couldn’t be ignored. I’d hope that instead of closing the clinic, some other option could be found. CSAT’s Nic Reuter, interviewed for the ADAW piece, said that in extreme cases, a team of professionals could be requested from CSAT, to come to this program and make changes, help turn things around.

I’m also suspicious. A Duluth newspaper had run a weeklong series of articles critical of for-profit methadone clinics just before the order to close was issued. Is this a bad clinic or the victim of a witch hunt? Were the inspectors pressured to find flaws, or were the flaws chronic and egregious?

I’ve worked for one non-profit program with several different clinic sites, and I’ve worked for four for-profit sites. If I graded overall quality of care, I’d rank the non-profit program fourth.  Just because a program is non-profit doesn’t mean it’s well-run, and for-profit clinics often are extremely well-run. From my personal experience, the bias against for-profit programs isn’t justified.

Colonial owns fifty-eight clinics in seventeen states, according to the ADAW article. I’ve never worked at a Colonial clinic, but I do know they’ve had problems in other states.

At one Colonial program near me, I heard from several of their former patients that their clinic once ran short of methadone. According to these two sources, the clinic reduced everyone’s dose until they could procure more methadone. I would die of embarrassment if I worked for a clinic that did such a thing. I would much rather guest dose everyone at a nearby clinic so that the patients didn’t de-stabilize. Guest-dosing would likely cost both clinic and patients extra money, though.

The Colonial programs in my area also allow methadone patients to have prescriptions for benzodiazepines, because I’ve had a few patients transfer for that reason. In my medical opinion, this is prohibitively risky for most patients, though may be appropriate for a limited few.

I’m more suspicious than the average person because I’ve worked at a well-run clinic that was the victim of an apparent witch hunt. I believe the pair of inspectors from the state’s Division of Health Service Regulation arrived with an agenda…to uncover nefarious doings at the methadone clinic. Their routine would have been comedic, if the outcome hadn’t been so awful.

Prior to this encounter, I’ve had positive experiences with the state’s methadone clinic inspectors. They were educated and competent, and often able to suggest ways to do things better and more efficiently, based on what they’ve seen at other clinics. Before I encountered this pair, I viewed inspectors not as adversaries but as potential information resources.

These two were different. They caused one problem after another at the clinic they were inspecting. I wasn’t there, but heard second hand that they interrogated nurses and counselors in an aggressive and demeaning manner. I believe these accounts, because they did the same with me.

After several days spent inspecting and disrupting the clinic, they wanted to talk to me because I was the medical director at that time. First of all, they were an hour and a half late for our appointment, which did not endear me to them. When they finally appeared, their dress and demeanor didn’t inspire confidence that a fair evaluation was about to be done. One of them was openly hostile to methadone maintenance treatment and the other didn’t say anything…but she wore an outfit that could be fittingly accessorized by a lamppost and a public defender, if you get my drift.

The spokeswoman of the two was a nurse – she kept reminding me of that for some reason – who would ask questions along the lines of, “Have you stopped endangering patients yet?” A yes or no answer wasn’t possible. Plus, at first, part of my mind was distracted, marveling at the silent partner’s outfit. I was wondering if I could ever get away with wearing an ensemble like that to work. Probably not, since we couldn’t even wear open-toed shoes…plus, was I a little too long in the tooth to be able to pull it off?….Maybe if I had tattoos like her…

“Why do you let patients keep going up on their dose?” Her aggressive tone snapped me back to attention. “Wouldn’t you agree few people need more than 70mg?” I tried to educate her that best results were seen when patients were at blocking doses, and that 70mg wasn’t a blocking dose for many people. She stared at me over the top of her reading glasses for a long moment. Then she sighed deeply and slowly shook her head side to side as she wrote something on her papers.

Then she said I was providing substandard care by not doing EKGs on patients. This was in 2007, and ironically enough I’d just returned the week before from an ASAM conference where we talked in detail about whether EKGs should be done and under what circumstances. I told her there was no clear consensus yet, but that may become the standard of care. She argued, said no, I was wrong, that was the standard of care now.

She asked why patients with positive drug screens were allowed to remain in treatment. My eyelid started to twitch about them, because it was clear she knew nothing about methadone maintenance treatment, but held a strong bias against it. I told her many patients have positive drug screens, and we see best results by keeping them engaged in treatment. If they’re still using opioids, we actually need to increase their dose, as I described before. And she argued with me about that.

I asked if she’d ever inspected methadone clinic before ours. She said no, but that she was a seasoned state inspector. Hoping to educate her, I asked her if she was familiar with TIP 43, SAMHSA’s published guideline to methadone treatment of opioid addiction. She said no. I jumped up and ratted around in several counselors’ offices, finally finding a copy that wasn’t too dog eared. I gave it to her, hoping she would read it. If she’d read it before trying to inspect a methadone clinic, she’d have known how to do her job better.

The next day, I wrote a complaint letter to her supervisor at the state, describing her objectionable behavior and lack of knowledge. I heard nothing more until a few months later, when a disjointed and rambling report, authored by the nurse inspector, accused my clinic of numerous misdeeds. We were charged with two major level one violations and charged thousands of dollars in fines for substandard care.

Her report was so jumbled that I couldn’t tell specifically what the violations were, but they seemed to focus on a patient in methadone maintenance who had surgery and received post-operative pain pills. Her report said this could have caused a fatality and was substandard care. (So much for my hope that she would read TIP 43!). This patient had actually received great care. Release of information was passed both ways, to and from her methadone clinic. She didn’t relapse on her post-op prescriptions, and had no problems. But this inspector thought she ought not to have been allowed to take opioids post-operatively.

This report was released to local media, and an article based on her report landed on the front page of the city paper. The real facts – that this woman didn’t have the education to be able to know if a clinic was well-run or not – weren’t known to the writer at the paper. Our clinic, coincidently a non-profit, took the case to court. Possibly to avoid a public hearing, the state dropped the level one charges and the fines. The clinic was left with several misdemeanor violations, easily cleared up. Everyone seemed happy but I still object to the misplaced power this woman had. I had looked forward to a public hearing so that flaws of the present system could be exposed and fixed. This inspector had caused harm to our clinic’s reputation.

This year, five years later after that episode, I heard this same inspector, still employed by the state, gave a very negative report of another clinic. The regional director of that clinic described it as an unfair hatchet job, and I have no doubt that’s true. I don’t understand why the state allows such a person to represent them in the field.

So in summary, the Duluth Colonial program may be a bad clinic that should be overhauled and possibly managed by a special team if other treatment options can’t be located for the patients. Or it may have received unfair assessment by someone with a political axe to grind.  Things are not always what they appear to be in the world of medication-assisted treatment.

Tennessee’s Vision for Mental Health

“Prejudice is a great time saver. You can form opinions without having to get the facts.”   E. B. White

You’d think I’d get tired of bashing Tennessee’s Department of Mental Health, but nope, not yet. That agency is like popcorn stuck between my teeth. It’s so annoying.

Mr. Doug Varney, the new leader of Tennessee’s Department of Mental Health, has a negative opinion of medication-assisted therapies, as I’ve discussed in prior blog entries.

Among his misconceptions, he’ made some curious statements about the for-profit status of opioid treatment programs seeking to open programs to treat Tennessee’s mass of opioid addicts.

According to the Kingsport Times-News, Mr. Varney said, “All the financial incentives are for them to keep people maintained on methadone as opposed to being drug-free,” he said. “I have a problem when I read the applications and one of the goals of the program that measures their outcome is that the person will still be coming to the clinic two years later. There’s no detox there.”  (1)

Yet as reviewed in my previous blog entry, the American Society of Addiction Medicine’s position paper on the use of methadone to treat addiction says quite the opposite, recommending …“Discontinuation of methadone maintenance should be attempted only when strongly desired by the rehabilitated patient…” and “Arbitrary caps on the number of patients who can be treated by a physician, the dosage of medication which is allowed, or the duration of treatment with methadone are not supported by medical evidence and should not be imposed by law, regulation, or health insurance practices.” (2)

ASAM is made up of physicians who specialize in treating addiction. They are the most knowledgeable doctors in the nation about addiction and treatment. For all other diseases, this would qualify them to set treatment standards.

Not in Tennessee.

In Tennessee, Mr. Varney’s personal opinions override evidence-based medical treatment. It’s a triumph of ideology over medicine, and it adversely affects opioid addicts all across Tennessee. This is something that would not be tolerated in any other field of medical care.

It sounds like Mr. Varney thinks addiction treatment facilities should be non-profit, to remove the financial motive for treatment. If so, I don’t necessarily disagree with him, but it would be an unusual position for an appointed public official to take in Tennessee, a state with a Republican governor.

Right now, medical care is a business in the U.S. I’m not particularly happy about that, and have my own opinions, but that’s the current state of affairs in this country. There’s no reason why the treatment of addiction is any different than the treatment of any other disease. For-profit companies own hospitals, doctors’ offices, x-ray facilities, nursing homes, and so on. Therefore Mr. Varney’s protestations about for-profit facilities make no sense given the realities of medical care in the U.S. today.

Besides, I’ve personally worked for one non-profit opioid treatment center, and four for-profit opioid treatment centers. The non-profit clinic didn’t give the best care of the five. At least two of the for-profit clinics gave better care, so I don’t think it necessarily helps the patients to go to a non-profit opioid treatment program, unless they have some sort of government funding. And then the care may be more affordable, not necessarily better.

Mr. Varney should be grateful for any opioid treatment program, non-profit or for-profit, willing to open a facility in his state. I can only imagine how difficult it is for the existing opioid treatment programs in that state, subjected to regulations that fly in the face of good patient care. Not to mention that every dollar these self-pay patients spend on medication-assisted treatment would save Tennessee taxpayers a minimum of $4 in expenditures, mostly in reduced incarceration expenses and reduced healthcare costs. (3)

  1. http://www.mapinc.org/drugnews/v04/n1408/a02.html
  2. http://www.asam.org/docs/publicy-policy-statements/1methadone-rev-10-061.pdf?sfvrsn=0#search=”methadone
  3. California Department of Drug and Alcohol Programs, 2004, California drug and alcohol treatment assessment (CALDATA) California Department of Alcohol and Drug Programs. California Drug and Alcohol Treatment Assessment (CALDATA), 1991-1993 [Computer File]. ICPSR02295-v2. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2008-10-07. doi:10.3886/ICPSR02295

Inmates with False Positive Drug Tests Accused of Taking Suboxone

According to news reports, inmates in Attica, New York, were wrongly accused of using buprenorphine (generic for the active medication in Suboxone and, Subutex). Apparently their urine drug screening system had a glitch, and nearly fifty inmates had these false positive screens. The prisoners, their lawyers, and their families badgered the Department of Corrections to investigate further, and when they did question the drug testing company, the unexpected results were found to be due to lab error. Until the error was acknowledged, inmates received sanctions and punishments including solitary confinement. It took a little over a month to discover the tests were in error, but at least the error was caught and acknowledged.

This is a good example of the lack of credibility addicts and inmates have. If a known addict protests a positive drug screen, much of the time they’re assumed to be lying. It’s not only law enforcement personnel who think this way; treatment center personnel can begin to believe all addicts are lying when they say their drug test results are wrong.

We must remember that no test is 100% correct and there will be false positives (the test shows drug use where none occurred) and false negatives (drug use occurred but wasn’t detected by the test) on screening tests. Granted, the rates of error are fairly low, but if you do enough tests, some addicts will be falsely accused of using drugs that they didn’t use.

That’s why secondary testing is crucial for contested results.

Most drug testing has two parts. The first screening test is quick, cheap, and relatively accurate. Most of the time, this test is sufficient. But in situations where positive tests have major negative consequences for the person being tested, a second, more accurate (and more expensive) test should be offered.

The second test is usually based on gas chromatography. If chain of custody has been maintained, the results of this test meet the legal standard of “beyond a reasonable doubt.” In other words, while no test is 100%, this test is so close that the courts accept it as proof.

At the opioid treatment programs where I’ve worked, many patients claim that their positive screening tests are in error, and they haven’t used the drug in question. That’s when the second test should be offered. However, gas chromatography is more expensive, and the issue becomes who should pay this extra thirty to forty dollars – the treatment center or the patient?

At one treatment center where I’ve worked, staff tells the patient that the second test will be done if the patient requests, but if the test is confirmed as being a true positive, the patient pays the cost of the second test. If the second test does NOT confirm the questioned result, the treatment program bears the cost. Thus, most people who know they’ve used the drug in question don’t request the second test because it’s a waste of their money. And patients who know they haven’t used are understandably eager to have the second test done on their sample, so they can prove their continued abstinence from drugs.

Drug testing is essential in the treatment of addiction, but treatment centers should make sure their tests are done by a certified lab and interpreted by a trained physician if questions arise. Confirmatory testing should be offered as an option to patients who question screening results.

Epic Fail: Tennessee’s Department of Mental Health

I admit I’ve been a little obsessed with Tennessee’s misguided approach to treating opioid addiction. It sticks in my craw. I can’t get over how backward their attitudes and approaches to the treatment of prescription opioid addiction have been, and I’m struggling to find out why Tennessee is the way it is. I hate bad science and ignorance. It grieves me to see the senseless suffering of the state’s addicted citizens.

I’ve been combing the internet and have found information that makes my right eyelid twitch. In the January 28, 2012 issue of the Tennessean, (1) Doug Varney is named as the new head of Tennessee’s Department of Mental Health. According to this article, he says Tennessee’s opioid treatment programs should to do a “better job” of weaning people off methadone and into detoxification programs. He says there’s no evidence to show methadone helps pain pill addicts as it does heroin addicts. He feels there are more appropriate treatments. In the past, Mr. Varney has been on record as saying methadone doesn’t accomplish anything because it’s merely switching one drug to another.

Yikes. This shows he understands about as much as the person who says methadone is “like giving whiskey to the alcoholic.” I’m not surprised when an average person says such things, because most people don’t know much about methadone, and are misinformed. But this person is the head of Tennessee’s Department of Mental Health!

I suspect he’s also behind the new proposed rules for Tennessee’s opioid treatment centers. Some of the proposed rules are good, and deal with quality of care. And others are harmful, and contradict what we know to be good medical practice.

For example, the new rules say an opioid addict needs to fail at two attempts at drug-free treatment before being allowed to enter an opioid treatment program. Where’s the science to back up that position? There is none. I challenge Mr. Varney to produce evidence showing two attempts at drug-free treatment do anything to help the addict. We know with detoxification alone, relapse rates are consistently in the range of 92-98%. We’ve known this since the old days at the Lexington, KY Narcotic Farm, established in 1935. The data are unchanged today with pain pill opioid addicts.

Besides, where will Tennesseans get this drug-free treatment? I’ve tried, and watched addition counselors try for hours to get opioid addicts into drug-free treatment in Tennessee. On the rare occasions when I’ve seen an opioid addict from Tennessee for whom methadone isn’t the best treatment, it’s next to impossible to find an inpatient treatment center eager to admit this patient. Even if there’s no waiting list for beds, the patients don’t have the money to afford it. And if state money pays for treatment, opioid addicts are rarely kept long enough to really help them. As above, short inpatient admissions accomplish little besides just detoxification, and that’s insufficient. With opioid addiction, patients need more than a month-long admission if drug-free treatment is undertaken. Otherwise it’s a waste of time and money,  sets the addict up for failure. and their family for disappointment.

The proposed rules say that after four positive urine drug screens within six months, the patient on methadone maintenance should be discharged from treatment. Are you kidding me? That runs counter to good medical practice.

Of course, people could say I’m biased because I make my living treating opioid addicts. OK, don’t take my word for it. Let’s consult the American Society of Addiction Medicine, the nation’s most prestigious group of medical doctors, educated and dedicated to the treatment of addiction. The Society has a position paper regarding methadone maintenance which says,

 “Discontinuation of methadone maintenance should be attempted only when strongly desired by the rehabilitated patient…” (2) ASAM’s paper correctly explains the high risk of death for a patient discharged from methadone maintenance. The literature shows death rates for patients who leave or who are terminated from opioid treatment programs spike significantly, to at least eight times the rate of patients who stay in medication-assisted treatment.

Another ill-advised new rule says that permission must be granted for doses higher than 120mg, and the state methadone authority must be notified for any dose rising about 100mg. Again, what does the evidence show? Let’s go to ASAM’s position paper: “Arbitrary caps on the number of patients who can be treated by a physician, the dosage of medication which is allowed, or the duration of treatment with methadone are not supported by medical evidence and should not be imposed by law, regulation, or health insurance practices.” Their position paper is backed by numerous study citations, and thus based on solid eveidence, not personal feelings.

In other words, the addiction medicine physicians have warned against the very actions that Mr. Varney is proposing. ASAM says it’s bad medical practice. They are physicians. Mr. Varney is not.

Mr. Varney needs to realize how serious this is. These proposed new rules for opioid treatment programs have the potential to further increase Tennessee’s opioid overdose death rates. It’s high enough as it is, as 13th highest in the nation. And remember from my past blogs, Tennessee is second highest in the nation for number of opioid prescriptions written, adjusted for population.

How did this guy get into a position of such power? What a disaster! State officials with this kind of authority to impact the lives of citizens have a moral obligation to do what’s best for citizens. Clearly, Tennessee’s Department of Mental “Health” is allowing personal prejudice to get in the way of sound medical practice. Is this even legal?? It makes me wish I lived in Tennessee, if only to vote against whichever administration selected this man to run the state’s Department of Mental Health.

There are actions we can take. Write to Mr. Varney and let him know you don’t think he should propose legislation for actions that knowledgeable physicians have deemed bad medical practice.

Here’s the mailing address:

Tennessee Department of Mental Health
Central Office

11th Floor, Andrew Johnson Tower
710 James Robertson Parkway
Nashville, Tennessee 37243
(615) 532-6500

Or, even quicker, send an email: OCA.Tdmh@tn.gov

Join with other advocates of appropriate, evidence-based medication-assisted treatment at the website of the National Alliance of Medication Assisted Recovery. You’ll see on their homepage that Tennessee is at the top of the list of their advocacy concerns: http://www.methadone.org/  They have some alternative email and regular mail addresses that may work better than the ones above.

  1. http://www.tennessean.com/article/20120128/NEWS07/301280024/TN-methadone-clinics-could-get-new-rules
  2. http://www.asam.org/docs/publicy-policy-statements/1methadone-rev-10-061.pdf?sfvrsn=0#search=”methadone
Follow

Get every new post delivered to your Inbox.

Join 213 other followers